Importance In atrial fibrillation (AF)–related acute ischemic stroke, the optimal oral
anticoagulation strategy remains unclear. Objective To test whether rivaroxaban or warfarin …

Background It is unknown whether renal dysfunction conveys poor anticoagulation control in
warfarin‐treated patients with atrial fibrillation and whether poor anticoagulation control …

Background\Anticoagulation is used for stroke prophylaxis in non-valvular atrial fibrillation,
amongst other by use of the vitamin K antagonist, warfarin. Quality in warfarin therapy is …

Atrial fibrillation increases the risk of stroke, which is a leading cause of death and disability
worldwide. The use of oral anticoagulation in patients with atrial fibrillation at moderate or …

Abstract Aims Oral anticoagulants (OACs) effectively reduce the risk of stroke in atrial
fibrillation (AF). Three non-vitamin K antagonist OACs (NOACs) are introduced in regular …

Objective We assessed the influence of age on warfarin dose, percentage time in target
range (PTTR), and risk of major hemorrhage. Design Warfarin users recruited into a large …

The novel oral anticoagulants or direct oral anticoagulants (DOAC) are becoming more
common in clinical practice for the prevention of stroke in non-valvular atrial fibrillation …

Stroke prevention, achieved with oral anticoagulation therapy (OAT), is central to the
management of patients with atrial fibrillation (AF). Well-managed OAT, as reflected by a …

Background The aim of this study was to evaluate the effects of a brief dyadic cognitive
behavioural therapy (CBT) programme on the health-related quality of life (HRQoL), as well …

Health care in Sub-Saharan Africa is being challenged by a double burden of disease as
lifestyle diseases common in the developed world, such as stroke and atrial fibrillation (AF) …